{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:01:00Z","timestamp":1761102060435},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,6,29]],"date-time":"2013-06-29T00:00:00Z","timestamp":1372464000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s00415-013-7011-2","type":"journal-article","created":{"date-parts":[[2013,6,28]],"date-time":"2013-06-28T18:16:15Z","timestamp":1372443375000},"page":"2523-2531","source":"Crossref","is-referenced-by-count":15,"title":["Clinical, genetic, and brain sonographic features related to Parkinson\u2019s disease in Gaucher disease"],"prefix":"10.1007","volume":"260","author":[{"given":"Tobias","family":"B\u00f6ttcher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arndt","family":"Rolfs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Grossmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kropp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Benecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Walter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,6,29]]},"reference":[{"key":"7011_CR1","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0140-6736(09)60492-X","volume":"373","author":"AJ Lees","year":"2009","unstructured":"Lees AJ, Hardy J, Revesz T (2009) Parkinson\u2019s disease. Lancet 373:2055\u20132066","journal-title":"Lancet"},{"key":"7011_CR2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/qjmed\/89.9.691","volume":"89","author":"O Neudorfer","year":"1996","unstructured":"Neudorfer O, Giladi N, Elstein D et al (1996) Occurrence of Parkinson\u2019s syndrome in type I Gaucher disease. QJM 89:691\u2013694","journal-title":"QJM"},{"key":"7011_CR3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mgme.2001.3201","volume":"73","author":"N Tayebi","year":"2001","unstructured":"Tayebi N, Callahan M, Madike V et al (2001) Gaucher disease and Parkinsonism: a phenotypic and genotypic characterization. Mol Genet Metab 73:313\u2013321","journal-title":"Mol Genet Metab"},{"key":"7011_CR4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/archneur.65.10.1353","volume":"65","author":"O Goker-Alpan","year":"2008","unstructured":"Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353\u20131357","journal-title":"Arch Neurol"},{"key":"7011_CR5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S1096-7192(03)00071-4","volume":"79","author":"N Tayebi","year":"2003","unstructured":"Tayebi N, Walker J, Stubblefield B et al (2003) Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to Parkinsonism? Mol Genet Metab 79:104\u2013109","journal-title":"Mol Genet Metab"},{"key":"7011_CR6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/mds.22593","volume":"24","author":"I Kraoua","year":"2009","unstructured":"Kraoua I, Stirnemann J, Ribeiro MJ et al (2009) Parkinsonism in Gaucher\u2019s disease type 1: ten new cases and a review of the literature. Mov Disord 24:1524\u20131530","journal-title":"Mov Disord"},{"key":"7011_CR7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"JR Mazzulli","year":"2011","unstructured":"Mazzulli JR, Xu YH, Sun Y et al (2011) Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies. Cell 146:37\u201352","journal-title":"Cell"},{"key":"7011_CR8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E Sidransky","year":"2009","unstructured":"Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease. N Engl J Med 361:1651\u20131661","journal-title":"N Engl J Med"},{"key":"7011_CR9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/hmg\/ddq454","volume":"20","author":"S Lesage","year":"2011","unstructured":"Lesage S, Anheim M, Condroyer C et al (2011) Large-scale screening of the Gaucher\u2019s disease-related glucocerebrosidase gene in Europeans with Parkinson\u2019s disease. Hum Mol Genet 20:202\u2013210","journal-title":"Hum Mol Genet"},{"key":"7011_CR10","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1212\/01.wnl.0000304039.11891.29","volume":"70","author":"Z Gan-Or","year":"2008","unstructured":"Gan-Or Z, Giladi N, Rozovski U et al (2008) Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset. Neurology 70:2277\u20132283","journal-title":"Neurology"},{"key":"7011_CR11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1212\/WNL.43.9.1693","volume":"43","author":"JP Hubble","year":"1993","unstructured":"Hubble JP, Cao T, Hassanein RE, Neuberger JS, Koller WC (1993) Risk factors for Parkinson\u2019s disease. Neurology 43:1693\u20131697","journal-title":"Neurology"},{"key":"7011_CR12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1212\/WNL.47.1.155","volume":"47","author":"K Marder","year":"1996","unstructured":"Marder K, Tang MX, Mejia H et al (1996) Risk of Parkinson\u2019s disease among first-degree relatives: a community-based study. Neurology 47:155\u2013160","journal-title":"Neurology"},{"key":"7011_CR13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/mds.25192","volume":"28","author":"D Berg","year":"2013","unstructured":"Berg D, Seppi K, Behnke S et al (2013) Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson\u2019s disease. Mov Disord 28:216\u2013219","journal-title":"Mov Disord"},{"key":"7011_CR14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S1474-4422(08)70239-4","volume":"7","author":"D Berg","year":"2008","unstructured":"Berg D, Godau J, Walter U (2008) Transcranial sonography in movement disorders. Lancet Neurol 7:1044\u20131055","journal-title":"Lancet Neurol"},{"key":"7011_CR15","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/archneur.59.6.999","volume":"59","author":"D Berg","year":"2002","unstructured":"Berg D, Roggendorf W, Schr\u00f6der U et al (2002) Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999\u20131005","journal-title":"Arch Neurol"},{"key":"7011_CR16","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/mds.23046","volume":"25","author":"R Saunders-Pullman","year":"2010","unstructured":"Saunders-Pullman R, Hagenah J, Dhawan V et al (2010) Gaucher disease ascertained through a Parkinson\u2019s center: imaging and clinical characterization. Mov Disord 25:1364\u20131372","journal-title":"Mov Disord"},{"key":"7011_CR17","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1212\/WNL.0b013e318225ab77","volume":"77","author":"K Brockmann","year":"2011","unstructured":"Brockmann K, Srulijes K, Hauser AK et al (2011) GBA-associated PD presents with nonmotor characteristics. Neurology 77:276\u2013280","journal-title":"Neurology"},{"key":"7011_CR18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.parkreldis.2012.09.007","volume":"19","author":"MJ Barrett","year":"2013","unstructured":"Barrett MJ, Hagenah J, Dhawan V et al (2013) Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease. Parkinsonism Relat Disord 19:186\u2013191","journal-title":"Parkinsonism Relat Disord"},{"key":"7011_CR19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.parkreldis.2012.12.006","volume":"19","author":"N Kresojevi\u0107","year":"2013","unstructured":"Kresojevi\u0107 N, Mijajlovi\u0107 M, Peri\u0107 S et al (2013) Transcranial sonography in patients with Parkinson\u2019s disease with glucocerebrosidase mutations. Parkinsonism Relat Disord 19:431\u2013435","journal-title":"Parkinsonism Relat Disord"},{"key":"7011_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7011_CR21","first-page":"153","volume-title":"Recent developments in Parkinson\u2019s disease II, 1st edn","author":"S Fahn","year":"1987","unstructured":"Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson\u2019s disease rating scale. In: Fahn S, Marsden CD, Goldstein M, Calne DB (eds) Recent developments in Parkinson\u2019s disease II, 1st edn. Macmillan, New York, pp 153\u2013163"},{"key":"7011_CR22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1212\/01.WNL.0000072330.07328.D6","volume":"61","author":"ED Louis","year":"2003","unstructured":"Louis ED, Luchsinger JA, Tang MX, Mayeux R (2003) Parkinsonian signs in older people: prevalence and associations with smoking and coffee. Neurology 61:24\u201328","journal-title":"Neurology"},{"key":"7011_CR23","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","volume":"4","author":"AT Beck","year":"1961","unstructured":"Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561\u2013571","journal-title":"Arch Gen Psychiatry"},{"key":"7011_CR24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/000348940111001015","volume":"110","author":"T Hummel","year":"2001","unstructured":"Hummel T, Konnerth CG, Rosenheim K, Kobal G (2001) Screening of olfactory function with a four-minute odor identification test: reliability, normative data, and investigations in patients with olfactory loss. Ann Otol Rhinol Laryngol 110:976\u2013981","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"7011_CR25","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","volume":"130","author":"GF Longstreth","year":"2006","unstructured":"Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC (2006) Functional bowel disorders. Gastroenterology 130:1480\u20131491","journal-title":"Gastroenterology"},{"key":"7011_CR26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"7011_CR27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM (1958) The validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills 8:271\u2013276","journal-title":"Percept Mot Skills"},{"key":"7011_CR28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/jnnp-2011-301719","volume":"83","author":"K Busse","year":"2012","unstructured":"Busse K, Heilmann R, Kleinschmidt S et al (2012) Value of combined midbrain sonography, olfactory and motor function assessment in the differential diagnosis of early Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 83:441\u2013447","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"7011_CR29","volume-title":"Grundintelligenztest Skala 2 (CFT 20)","author":"RH Wei\u00df","year":"1998","unstructured":"Wei\u00df RH (1998) Grundintelligenztest Skala 2 (CFT 20), 4th edn. Hogrefe, G\u00f6ttingen","edition":"4"},{"key":"7011_CR30","volume-title":"Der Hamburg-Wechsler-Intelligenztest f\u00fcr Erwachsene","author":"U Tewes","year":"1997","unstructured":"Tewes U (1997) Der Hamburg-Wechsler-Intelligenztest f\u00fcr Erwachsene, 2nd edn. Hogrefe, G\u00f6ttingen","edition":"2"},{"key":"7011_CR31","volume-title":"Test d2\u2014Aufmerksamkeits-Belastungs-Test","author":"R Brickenkamp","year":"2002","unstructured":"Brickenkamp R (2002) Test d2\u2014Aufmerksamkeits-Belastungs-Test. Hogrefe, G\u00f6ttingen"},{"key":"7011_CR32","volume-title":"The Revised Visual Retention Test","author":"AL Benton","year":"1974","unstructured":"Benton AL (1974) The Revised Visual Retention Test, 4th edn. Psychological Corp., New York","edition":"4"},{"key":"7011_CR33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.211.2.r99ma53489","volume":"211","author":"J Vymazal","year":"1999","unstructured":"Vymazal J, Righini A, Brooks RA et al (1999) T1 and T2 in the brain of healthy subjects, patients with Parkinson disease, and patients with multiple system atrophy: relation to iron content. Radiology 211:489\u2013495","journal-title":"Radiology"},{"key":"7011_CR34","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1212\/WNL.46.4.1102","volume":"46","author":"PJ Seeman","year":"1996","unstructured":"Seeman PJ, Finckh U, H\u00f6ppner J et al (1996) Two new missense mutations in a non-Jewish Caucasian family with type 3 Gaucher disease. Neurology 46:1102\u20131107","journal-title":"Neurology"},{"key":"7011_CR35","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1086\/302925","volume":"66","author":"V Koprivica","year":"2000","unstructured":"Koprivica V, Stone DL, Park JK et al (2000) Analysis and classification of 304 mutant alleles in patients with type 1 and type 3 Gaucher disease. Am J Hum Genet 66:1777\u20131786","journal-title":"Am J Hum Genet"},{"key":"7011_CR36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bcmd.2005.07.005","volume":"35","author":"E Beutler","year":"2005","unstructured":"Beutler E, Gelbart T, Scott CR (2005) Hematologically important mutations: Gaucher disease. Blood Cells Mol Dis 35:355\u2013364","journal-title":"Blood Cells Mol Dis"},{"key":"7011_CR37","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.mop.0000172702.33128.19","volume":"17","author":"GA Grabowski","year":"2005","unstructured":"Grabowski GA (2005) Recent clinical progress in Gaucher disease. Curr Opin Pediatr 17:519\u2013524","journal-title":"Curr Opin Pediatr"},{"key":"7011_CR38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/mds.24945","volume":"27","author":"A McNeill","year":"2012","unstructured":"McNeill A, Duran R, Proukakis C et al (2012) Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord 27:526\u2013532","journal-title":"Mov Disord"},{"key":"7011_CR39","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.neuroimage.2009.05.072","volume":"47","author":"S Behnke","year":"2009","unstructured":"Behnke S, Schroeder U, Dillmann U et al (2009) Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET. Neuroimage 47:1237\u20131243","journal-title":"Neuroimage"},{"key":"7011_CR40","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1212\/WNL.0b013e3181b8a9f8","volume":"73","author":"U Walter","year":"2009","unstructured":"Walter U, Wagner S, Horowski S, Benecke R, Zettl UK (2009) Transcranial brain sonography findings predict disease progression in multiple sclerosis. Neurology 73:1010\u20131017","journal-title":"Neurology"},{"key":"7011_CR41","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ajh.21721","volume":"85","author":"P Stein","year":"2010","unstructured":"Stein P, Yu H, Jain D, Mistry PK (2010) Hyperferritinemia and iron overload in type 1 Gaucher disease. Am J Hematol 85:472\u2013476","journal-title":"Am J Hematol"},{"key":"7011_CR42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2012.04.002","volume":"49","author":"A Mekinian","year":"2012","unstructured":"Mekinian A, Stirnemann J, Belmatoug N et al (2012) Ferritinemia during type 1 Gaucher disease: mechanisms and progression under treatment. Blood Cells Mol Dis 49:53\u201357","journal-title":"Blood Cells Mol Dis"},{"key":"7011_CR43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuroimage.2010.01.112","volume":"51","author":"J Hagenah","year":"2010","unstructured":"Hagenah J, K\u00f6nig IR, Sperner J et al (2010) Life-long increase of substantia nigra hyperechogenicity in transcranial sonography. Neuroimage 51:28\u201332","journal-title":"Neuroimage"},{"key":"7011_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","volume":"33","author":"G Bultron","year":"2010","unstructured":"Bultron G, Kacena K, Pearson D et al (2010) The risk of Parkinson\u2019s disease in type 1 Gaucher disease. J Inherit Metab Dis 33:167\u2013173","journal-title":"J Inherit Metab Dis"},{"key":"7011_CR45","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10545-012-9527-5","volume":"36","author":"MJ Barrett","year":"2013","unstructured":"Barrett MJ, Giraldo P, Capablo JL et al (2013) Greater risk of Parkinsonism associated with non-N370S GBA1 mutations. J Inherit Metab Dis 36:575\u2013580","journal-title":"J Inherit Metab Dis"},{"key":"7011_CR46","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00401-010-0741-7","volume":"120","author":"O Goker-Alpan","year":"2010","unstructured":"Goker-Alpan O, Stubblefield BK, Giasson BI, Sidransky E (2010) Glucocerebrosidase is present in \u03b1-synuclein inclusions in Lewy body disorders. Acta Neuropathol 120:641\u2013649","journal-title":"Acta Neuropathol"},{"key":"7011_CR47","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.22400","volume":"69","author":"V Cullen","year":"2011","unstructured":"Cullen V, Sardi SP, Ng J et al (2011) Acid \u03b2-glucosidase mutants linked to Gaucher disease, Parkinson disease, and Lewy body dementia alter \u03b1-synuclein processing. Ann Neurol 69:940\u2013953","journal-title":"Ann Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7011-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-013-7011-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-013-7011-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T19:23:15Z","timestamp":1559071395000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-013-7011-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,29]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["7011"],"URL":"https:\/\/doi.org\/10.1007\/s00415-013-7011-2","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,29]]}}}